Summer 2022 (Volume 32, Number 2)
By Philip A. Baer, MDCM, FRCPC, FACR
For the seventh consecutive year, RheumJeopardy
returned as a plenary session at the 2022 CRA
ASM. The virtual format again required some
adjustments to work on the HOPIN meeting platform,
but the essence of the game experience was
preserved. I moderated from my home office with the
expert technical assistance of the team from MKEM.
After a 0-0 tie in the 2021 edition, Dr. Alexandra
Legge returned as Chair and scorekeeper. We maintained
the traditional East versus West format, with
Toronto the dividing line again this year. Our team
captains were Dr. Valérie Leclair from Montreal and
Dr. Alison Clifford from Edmonton. As in 2021, only
the members of the team whose captain had selected
a question voted on the answer, which had the
effect of lowering the potential scores. The team
captains selected the Final Jeopardy wagers and
answered the Final Jeopardy question on their own.
The session drew a large audience of enthusiastic
participants, with 299 meeting delegates participating
live. After a practice question related to the
worst Jeopardy score ever (-$7,400), 14 questions
were selected in the main game. They proved to
be challenging, but our teams were more than up
to the task. Potpourri/COVID and Sight Diagnoses
were the most popular categories. The CRA Education
Committee contributed three questions on
Competency by Design (CBD), and two were selected.
One stumper related to the frequency of joint
infection after steroid injections. The answer selected was
1 in 10,000, whereas the Danish study cited found an incidence
of 1 in 1,250.
In honour of Dr. Simon Carette presenting the Dunlop-
Dottridge Lecture on “Vasculitis: What Have We
Learned in the Past 50 Years?”, four RheumJeopardy questions
dealt with various types of vasculitis: giant cell arteritis
(GCA), granulomatosis (GPA), systemic lupus erythematosus
(SLE) vasculitis and anti-neutrophil cytoplasmic
antibodies (ANCA)-associated vasculitis.
At the end of the main Jeopardy round, the score favoured
West with 5,200 over East with 3,700. Both captains
broke with tradition, perhaps related to the score,
and did not elect to wager everything on the Final Jeopardy
question. The category was “WHO Award Winners”,
rather than the traditional “Famous Canadian Rheumatologists.”
In keeping with the meeting theme of “Towards
Equity: Rheum for Everyone,” the question focused on
women overlooked in scientific history. Rosalind Franklin,
who played a key role in the discovery of the structure of
deoxyribonucleic acid (DNA), and Lise Meitner, who was a
pioneer in nuclear fission, were potential answer choices.
However, the correct answer was Henrietta Lacks, whose
cervical cancer cells were used without her permission to
develop the HeLa line of immortalized cells which have
been used for 70 years in scientific research, and whose
unauthorized use remains the subject of current lawsuits.
That question stumped both team captains. East had
wagered 66% of their score, while West with the lead had
wagered only 33%. That left West as the winning team with
3,467 versus East’s score of 1,267. That means Dr. Alison
Clifford will likely chair RheumJeopardy in 2023 in Quebec
City if the ASM Scientific Committee grants us a place on
the agenda. Let’s hope so!
Philip A. Baer, MDCM, FRCPC, FACR